Obstetrics and Gynecology Hospital, Fudan University Shanghai, People's Republic of China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University Shanghai, People's Republic of China.
Obstetrics and Gynecology Hospital, Fudan University Shanghai, People's Republic of China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University Shanghai, People's Republic of China.
Reprod Biomed Online. 2022 May;44(5):803-816. doi: 10.1016/j.rbmo.2022.01.016. Epub 2022 Feb 3.
Increased granulosa cell division is associated with abnormal folliculogenesis in polycystic ovary syndrome (PCOS). Lethal-7i microRNA (let-7i) may play an important role in the follicular development and granulosa cell growth; therefore is let-7i involved in PCOS pathogenesis?
The expression of let-7i was measured in granulosa-luteal cells (GLC) from women with or without PCOS. A human granulosa cell line, KGN, was used for the functional study. Mimics and inhibitors of let-7i, lentiviruses expressing insulin-like growth factor 2 mRNA binding protein (IMP2), and small-interfering RNAs were transfected into KGN cells. KGN cell proliferation was determined by 5-ethynyl-2'-deoxyuridine (EdU) and Cell Counting Kit-8 (CCK-8) assays. The cell cycle and apoptosis were assessed by propidium iodide-annexin V (PI-A) staining and fluorescence-activated cell sorting. Oestradiol concentration was determined by enzyme-linked immunoassay. Bioinformatics analysis and luciferase reporter assay were applied to confirm the let-7i target genes.
The study showed that let-7i was down-regulated in PCOS GLC (P = 0.001). Mimics of let-7i inhibited KGN proliferation (P = 0.001), and decreased aromatase expression (P = 0.030) and oestradiol production (P = 0.029), whereas let-7i inhibitors had the opposite effect. Bioinformatics analysis and quantitative real-time (qRT) PCR identified IMP2 as a target of let-7i (P = 0.021). qRT-PCR and western blot analysis indicated that IMP2 was up-regulated in GLC in women with PCOS (P = 0.001 and P = 0.044), and IMP2 expression was suppressed by let-7i in KGN cells (P < 0.001). Luciferase reporter assay results (P = 0.002), combined with the rescue assay, confirmed that let-7i inhibited KGN cell proliferation and reduced oestradiol concentration by directly targeting IMP2.
let-7i was down-regulated in PCOS GLC. Overexpression of let-7i inhibited KGN cell proliferation and decreased oestradiol production in an IMP2-dependent manner, providing a new molecular mechanism for PCOS.
在多囊卵巢综合征(PCOS)中,颗粒细胞分裂增加与异常卵泡发生有关。致死-7i 微 RNA(let-7i)可能在卵泡发育和颗粒细胞生长中发挥重要作用;因此,let-7i 是否参与了 PCOS 的发病机制?
测量有无 PCOS 的女性颗粒细胞-黄体细胞(GLC)中的 let-7i 表达。用人颗粒细胞系 KGN 进行功能研究。转染 let-7i 的模拟物和抑制剂、表达胰岛素样生长因子 2 mRNA 结合蛋白(IMP2)的慢病毒和小干扰 RNA 进入 KGN 细胞。通过 5-乙炔基-2'-脱氧尿苷(EdU)和细胞计数试剂盒-8(CCK-8)测定 KGN 细胞增殖。通过碘化丙啶-膜联蛋白 V(PI-A)染色和荧光激活细胞分选评估细胞周期和凋亡。通过酶联免疫吸附试验测定雌二醇浓度。应用生物信息学分析和荧光素酶报告基因检测来确认 let-7i 的靶基因。
研究表明,PCOS GLC 中 let-7i 下调(P=0.001)。let-7i 的模拟物抑制 KGN 增殖(P=0.001),并降低芳香化酶表达(P=0.030)和雌二醇产生(P=0.029),而 let-7i 抑制剂则有相反的效果。生物信息学分析和实时定量(qRT)PCR 鉴定 IMP2 为 let-7i 的靶基因(P=0.021)。qRT-PCR 和 Western blot 分析表明,PCOS 患者的 GLC 中 IMP2 上调(P=0.001 和 P=0.044),let-7i 在 KGN 细胞中抑制 IMP2 表达(P<0.001)。荧光素酶报告基因检测结果(P=0.002),结合挽救试验,证实 let-7i 通过直接靶向 IMP2 抑制 KGN 细胞增殖并降低雌二醇浓度。
PCOS GLC 中 let-7i 下调。let-7i 的过表达以 IMP2 依赖的方式抑制 KGN 细胞增殖并减少雌二醇产生,为 PCOS 提供了新的分子机制。